6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
1h ago	BLINDED ASSESSMENT OF ACTION3 STATISTICAL ASSUMPTIONS COMPLETE
2h ago	Pinnacle Silver and Gold Commences Trading on OTCQB
2h ago	Apogee Minerals Announces Non-Brokered Private Placement Financing
2h ago	Honey Badger Silver Closes Transformative Acquisition of the Important PC Silver Project in the Northwest Territories
2h ago	Mayfair Gold Provides Update on Project Work in the First Quarter of 2026 Advancing and Derisking the Fenn-Gib Gold Project

About

Cue Biopharma (NASDAQ:CUE) — investor relations, events, news, and company updates on 6ix.

Latest News

Cue Biopharma Announces 1-for-30 Reverse Stock Split

Cue Biopharma to Present New Preclinical Data on Lead Autoimmune and Inflammatory Disease Candidate CUE-401 at IMMUNOLOGY2026

Cue Biopharma to Receive $7.5 Million Preclinical Milestone Payment from Boehringer Ingelheim Collaboration and License Agreement

Cue Biopharma Announces CEO Transition

Cue Biopharma to Host Virtual R&D Day Event on April 7, 2026

Financials

Revenue

$27.47 M

Market Cap

$17.57 M

EPS

-0.28

Community Chat

Ask AI